维百奥现货销售Svar Lifescience现货试剂盒
| 产品信息
品名：Svar Lifescience现货试剂盒
品牌：Lifecore
| 产品系列
1）WIESLAB® Complement Alternative Pathway (RUO)
货号：COMPLAP330RUO
The Wieslab® Complement System Alternative Pathway kit is an enzyme immunoassay for the qualitative determination of functional alternative complement pathway and determination of complement deficiencies in human serum. Non-human primate and swine samples can also be assayed with Wieslab® Complement System Alternative pathway.
The Wieslab Complement assay combines tthe specific activation of the pathway with the use of labeled antibodies specific for a neoepitope of the terminal complement complex, C5b-9, produced as the result of complement activation. The amount of C5b-9 generated is proportional to the functional activity of the complement system. The convenient ELISA technology has several advantages compared to the traditional hemolytic assays.
2）WIESLAB® Complement MBL Pathway (RUO)
货号：COMPLMP320RUO
The Wieslab® Complement System MBL pathway kit is an enzyme immunoassay for the qualitative determination of MBL complement pathway and determination of complement deficiencies in human serum. Non-human primate and swine samples can also be assayed with Wieslab Complement System MBL Pathway.
The assay combines the specific activation of each pathway with the use of labeled antibodies specific for a neoepitope of the terminal complement complex, C5b-9, produced as a result of complement activation. The amount of C5b-9 generated is proportional to the functional activity of complement pathways.
3）WIESLAB® Complement Classical Pathway (RUO)
货号：COMPLCP310RUO
The Wieslab® Complement System Classical Pathway is an enzyme immunoassay for the qualitative and/or semi-quantitative determination of functional classical complement pathway and determination of complement deficiencies in human serum. Non-human primate and swine samples can also be assayed with Wieslab® Complement System Classical Pathway.
The Wieslab Complement System Classical Pathway assay combines the specific activation of the pathway with the use of labeled antibodies specific for a neoepitope of the terminal complement complex, C5b-9, produced as the result of complement activation. The amount of complement activation can be expressed either in a qualitative way relative the value of a positive control or in a semi-quantitative way using a calibrator curve derived from a separate lyophilized activity control.
关键字： COMPLAP330RUO;COMPLMP320RUO;COMPLCP310RUO;Svar试剂盒;
维百奥（北京）生物科技有限公司成立于2014年，经营范围包括: 技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广;仪器仪表制造;仪器仪表销售;仪器仪表修理;化工产品生产(不含许可类化工产品);化工产品销售(不含许可类化工产品);专用化学产品制造(不含危险化学品);专用化学产品销售(不含危险化学品);计算机系统服务;数据处理和存储支持服务;软件开发;工程技术服务(规划管理、勘察、设计、监理除外);新材料技术推广服务;进出口代理;货物进出口;技术进出口。(除依法须经批准的项目外，凭营业执照依法自主开展经营活动)(不得从事国家和本市产业政策禁止和限制类项目的经营活动。)